Boston: Superluminal Medicines, a drug discovery company integrating AI/ML, protein dynamics, and structural biology to ...

Eli Lilly (LLY) announced the upcoming retirement of Anne White, a pivotal figure in its neuroscience division, and entered a ...

The deal allows Eli Lilly and Company (NYSE:LLY) to have exclusive rights to develop and commercialize drug candidates ...

The deal allows Eli Lilly and Company (NYSE:LLY) to have exclusive rights to develop and commercialize drug candidates discovered with the help of Superluminal’s proprietary AI-driven platform ...

The deal allows Eli Lilly and Company (NYSE:LLY) to have exclusive rights to develop and commercialize drug candidates discovered with the help of Superluminal’s proprietary AI-driven platform ...

Now, 15 years of observations have revealed the answer. Using the Very Long Baseline Array, a team led by astronomer Yuri ...

Eli Lilly (LLY) has signed a $1.3 billion deal with privately held biotechnology firm Superluminal Medicines that will see ...

Science fiction enriches its stories by inventions like faster-than-light travel. Some are pure fiction, while others are ...

AI is speeding up drug discovery by designing new medicines faster and cheaper. It scans data, creates new molecules, and ...

Applied Materials, Inc.’s AMAT shares tumbled 14.1% after it issued a grim sales and profit outlook, stoking concerns that the U.S.-China trade dispute was hampering demand. Shares of UnitedHealth ...